Health
5.2
Brazil's Anvisa seizes counterfeit botulinum toxin batch, bans sale and use
Published 1 d ago1 sourceEvidence: Reported
SeverityModerateAssessedDeveloping storyPoder360BR
HealthReportedMedium
5.2
Brazil caps semestral HIV injection at R$20,914; not in SUS
Brazil's health regulator Anvisa set a price ceiling of R$20,914.22 for Sunlenca, a semestral HIV injection, but the drug is not sold in pharmacies nor available in the public health system (SUS). This creates a cost barrier for patients, highlighting access disparities in HIV treatment.
Score Breakdown
Mosaic Score5.2
Model confidence0.7
Significance0.5
Source credibility0.4
Related signals
8 foundHealth
2.0
Brazil SUS expands access to 9 cancer drugs for 116,000 patients
Published 2 h ago1 sourceEvidence: Reported
Poder360BR
Health
2.0
Peru updates HIV/Hep B/C medicine list after 3 years, adds pediatric combo
Published 5 h ago1 sourceEvidence: Reported
La República (Peru)Low-rated sourcePE
Politics
9.4
Brazil 2026 runoff set: Lula vs Bolsonaro, date confirmed
Published 1 d ago11 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyLa Nación (Argentina)Low-rated sourceBR
Politics
9.2
Brazil runoff: Lula and Flavio Bolsonaro statistically tied with week to go
Published 7 h ago5 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyDeutsche WelleBR · US
Politics
9.0
Brazil polls: Flávio leads in 12 of 13 surveys, 5 days before election
Published 13 h ago6 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyPoder360BR
Politics
9.0
Brazil Runoff Tight: Bolsonaro Son Leads Lula by 2 Points, Mass Rallies
Published 2 h ago5 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyEl DeberLow-rated sourceBR
Politics
8.8
Brazil polls show technical tie between Lula and Flávio entering final week
Published 1 d ago5 sourcesEvidence: Reported
SeverityHighAssessedDeveloping storyInfoMoneyBR